Profile
Ami Bavishi worked as the Director of Investor Relations at Aerie Pharmaceuticals, Inc. and later as the Head of Investor Relations & Corporate Communications at Rallybio Corp.
Mr. Bavishi is a graduate of George Washington University and holds an undergraduate degree from Duquesne University of The Holy Spirit.
Former positions of Ami Bavishi
| Companies | Position | End |
|---|---|---|
| RALLYBIO CORPORATION | Investor Relations Contact | 2024-03-31 |
| AERIE PHARMACEUTICALS, INC. | Investor Relations Contact | - |
Training of Ami Bavishi
| Duquesne University of The Holy Spirit | Undergraduate Degree |
| George Washington University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| RALLYBIO CORPORATION | Health Technology |
| Private companies | 1 |
|---|---|
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
- Stock Market
- Insiders
- Ami Bavishi
